# Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes

> **NCT05856578** · PHASE4 · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 60 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Mulberry Twig Alkaloid Tablet
- **DRUG:** Canagliflozin

## Key facts

- **NCT ID:** NCT05856578
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-15
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05856578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05856578, "Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05856578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*